Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

3.6K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.6K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic corepressor BCORL1 predominates as a driver of clonal hematopoiesis of indeterminate potential in patients undergoing chronic hemodialysis: a multicenter cohort study.

Human genomics·2026
Same author

Uncovering predictors of bipolar II conversion to bipolar I: A machine learning analysis of national health records in Taiwan.

Journal of affective disorders·2025
Same author

Predictive factors and survival associated with varying degrees of cytopenia in patients undergoing chronic Hemodialysis: A cohort study.

Journal of the Formosan Medical Association = Taiwan yi zhi·2025
Same author

Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.

Blood cancer journal·2025
Same author

A Rare Case of Complete Atrioventricular Block Induced by Lithium Toxicity: Impact of Drug Interactions With Telmisartan.

Cureus·2025
Same author

Impact assessment of spatial-temporal distribution of riverine dust on air quality using remote sensing data and numerical modeling.

Environmental science and pollution research international·2024

Related Experiment Video

Updated: Jun 25, 2025

Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

81.3K

Chromothripsis in myeloid malignancies.

Chien-Yuan Chen1,2

  • 1Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, 100, Taiwan. chienyuanchen@ntu.edu.tw.

Annals of Hematology
|May 30, 2024
PubMed
Summary
This summary is machine-generated.

Chromothripsis, a major genomic rearrangement, occurs in various cancers like acute myeloid leukemia (AML). Patients with chromothripsis often face poorer prognoses and lower remission rates, necessitating further research.

Keywords:
TP53 mutationChromothripsisComplex karyotypeMyeloid malignancy

More Related Videos

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.2K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.9K

Related Experiment Videos

Last Updated: Jun 25, 2025

Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

81.3K
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.2K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.9K

Area of Science:

  • Genomics
  • Cancer Biology
  • Hematology

Background:

  • Chromothripsis involves massive genomic rearrangements during a single catastrophic event.
  • It is observed in various malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
  • Incidence varies significantly based on malignancy type and specific genetic mutations, such as TP53.

Purpose of the Study:

  • To summarize the incidence, associated genetic factors, and clinical implications of chromothripsis in myeloid malignancies.
  • To highlight the prognostic impact of chromothripsis on treatment response and survival rates.

Main Methods:

  • Review of existing literature on chromothripsis in AML and MDS.
  • Analysis of reported incidences, genetic associations (e.g., TP53, ERG, FLT3, NPM1), and clinical outcomes.

Main Results:

  • Chromothripsis incidence ranges widely: 0-6.6% in AML, 27.3-100% in complex karyotype AML, 11.1-90% in AML with TP53 mutations.
  • Associated with complex karyotypes, TP53 mutations, and monosomal karyotypes; ERG amplifications are frequent, MYC amplifications are not.
  • Negatively associated with FLT3 and NPM1 mutations; typically occurs in older AML patients with low leukocyte and blast counts.
  • Associated with poor prognosis, including lower complete remission rates and worse overall survival in myeloid malignancies.
  • Signal pathways involve oncogene upregulation and tumor suppressor downregulation.

Conclusions:

  • Chromothripsis is linked to adverse outcomes in myeloid malignancies.
  • Further large-scale studies are crucial to understand its causes and develop targeted treatments.